#296 - The Truth About Protein: Why Exercise is the Secret to Muscle Growth and Longevity | Dr. Stuart Phillips & Mike Haney
LEVELS – A Whole New LevelShow Notes
Protein is often hailed as the ultimate nutrient for health and longevity, but the science suggests it is only half of the equation. While social media influencers debate the minutiae of protein grams, researchers have found that the vast majority of protein's benefits are "baked in" only when combined with physical activity. Without the stimulus of exercise, even the most optimized protein intake fails to move the needle on muscle growth or chronic disease prevention.
In this episode of A Whole New Level, Mike Haney sits down with Dr. Stuart Phillips, a researcher who has spent over 25 years at McMaster University studying the intersection of protein, exercise, and human health. Dr. Phillips breaks down why the current RDA for protein is likely too low for optimal health and why the methodology used to set those standards is decades out of date.
Dr. Phillips explains the "brick wall" analogy of muscle turnover—where synthesis and breakdown are in a constant tug-of-war—and how lifting weights acts as the primary driver for "the bricklayers". From the impact of anabolic resistance in aging to the truth about protein timing and kidney health, he provides a grounded, data-driven perspective on how to maintain a functional reserve of muscle as we age.
Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl
In this episode, we cover The RDA Debate: Why the standard 0.8 g/kg recommendation is a "preventing deficiency" baseline rather than an "optimized health" target. The Power of Exercise: Why 80% to 90% of protein's benefits are dependent on physical activity. Muscle as a Storage Depot: Understanding muscle as a functional reserve that dictates disease resistance and survival. Anabolic Resistance: How inactivity and aging make our cells less efficient at using amino acids. The Myth of Timing: Why the "anabolic window" is more like a "garage door" that stays open much longer than once thought. Protein Quality & Source: Comparing animal vs. plant proteins and why the "food matrix" matters more than isolated powders. Kidney Health: De-bunking the 60-year-old hypothesis that high protein intake causes kidney damage in healthy individuals.
🎙 What Dr. Stuart Phillips & Mike Haney discuss: [00:00] — Why exercise is the "big driver" of protein's health benefits. [09:00] — Transitioning from the RDA (0.8 g/kg) to an optimized range of 1.2 to 1.6 g/kg. [30:31] — The limitations of "nitrogen balance" as a methodology for protein needs. [44:45] — Muscle as a structural substrate vs. carbs and fats as fuel. [01:10:05] — Anabolic resistance: Why we lose building efficiency as we age. [01:18:15] — The "Compound Interest" of muscle: Why starting early prevents a late-life mobility spiral. [01:28:10] — Hormones and muscle: The differing impacts of testosterone and estrogen during aging. [01:39:15] — Addressing the concerns regarding high protein intake and kidney function. [01:52:10] — Whole foods vs. supplements: Why the "bricklayers" care about amino acids, but the body cares about nutrients. [01:60:12] — Debunking the immediate post-workout protein shake myth.
Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health.
Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.
🔗 Helpful links Watch the conversation: https://youtu.be/twVUPk-B-vg Find us on YouTube: https://youtube.com/levelshealth?sub_confirmation=1
📲 Connect Connect with Dr. Stuart Phillips on LinkedIn & X: https://www.linkedin.com/in/stuartmphillips/ https://x.com/mackinprof
More from LEVELS – A Whole New Level
Heart disease is the leading cause of death, but it’s also one of the most preventable. Decades of research have established a strong causal role for LDL and other ApoB-containing particles in atherosclerosis, and we now have multiple proven ways to lower them. The harder question is how to turn that evidence into a decision for an individual person. Mike Haney talks with Johns Hopkins cardiologist Dr. Seth Martin, a co-author of the new 2026 dyslipidemia guidelines, about what the latest evidence says we should actually measure and act on. The throughline is pragmatic: lower exposure to atherogenic particles earlier and for longer, use additional tests when they can change a decision, and distinguish interesting new measurements from ones that have actually been shown to improve outcomes.
Most of NextLevel starts with a measurement problem: we can see more biology than ever, but we still have to figure out what to do with it. Bioelectronic medicine flips that sequence. We already know how to send electrical signals into the nervous system to change biology, including an FDA-approved vagus nerve treatment for rheumatoid arthritis, even though we still can’t map or read most of the individual nerve fibers carrying those signals.
Most health decisions happen before the science is settled. A study points one way, another points somewhere else, experts disagree about what matters, and even strong population-level evidence may not tell you what will happen to you.
Most medical imaging happens after a symptom, injury, or abnormal test gives a clinician a reason to look. But what changes if imaging becomes a more routine measurement, creating a record of the body before something goes wrong? In this episode of Next Level, Mike Haney talks with Dr. Daniel Durand, chief medical officer at Prenuvo, about whole-body MRI as a test case for a broader shift from episodic medicine toward longitudinal health data. Whole-body MRI is controversial, and Durand is clearly an advocate. The conversation takes the skepticism seriously, then asks a larger question: as measurement gets cheaper, more frequent, and increasingly visible to patients themselves, how should medicine decide what is worth knowing?
Alcohol has spent the last 40 years bouncing between two health narratives: a little is good for your heart, or any amount is dangerous. The science doesn’t really support either slogan. Dr. Tim Naimi has spent decades studying the health effects of alcohol and, just as importantly, why the research is so difficult to interpret. His read of the evidence is less dramatic but more useful: there’s no good reason to start drinking for your health, very low intake may carry little measurable added risk, and risk rises as consumption does. Understanding why earlier studies made moderate drinking look protective helps explain a lot of the whiplashing headlines.